My Son has Fetal Valproate Syndrome a type of Fetal Anti Convulsant Syndrome (FACS) caused by Sodium valproate (Epilim, Depakote, Depakene) that I took while pregnant to control epilepsy. Despite the 40% risk of birth defects the UK medicine regulator (MHRA) is refusing to issue warnings. A group of people affected by the harmful side effects of pharmaceutical products held a peaceful protest on 2nd August 2013 at the MHRA Headquarters in London. http:// is linking people affected by all medications to build up a global campaign to raise awareness of poor medicine regulation. I have put a link to this page on the front page of the website. If you would like to get involved in our global campaign please email me and join the public facebook group (Fetal AntiConvulsant Trust) to discuss strategy and the development of the campaign. I look forward to hearing from you. thank you. emma friedmann
In controlled and uncontrolled clinical trials involving more than 5000 patients treated with ZYFLO, the overall rate of ALT elevation ≥ 3xULN was %. In these trials, one patient developed symptomatic hepatitis with jaundice , which resolved upon discontinuation of therapy. An additional 3 patients with transaminase elevations developed mild hyperbilirubinemia that was less than three times the upper limit of normal. There was no evidence of hypersensitivity or other alternative etiologies for these findings. In subset analyses, females over the age of 65 appeared to be at an increased risk for ALT elevations. Patients with pre-existing transaminase elevations may also be at an increased risk for ALT elevations (see CONTRAINDICATIONS ).